Loading...

TLSI TRISALUS LIFE SCIENCES INC Earnings Reports 8-K Filing

TRSL

TLS

TRISALUS LIFE SCIENCES INC

(TLSI)

2024 8-K

Show Summary

Show Summary

Financial Statements

Equity Offerings

Director Resignation

Financial Results

Management Change

Credit Facility Agreement

Credit Agreement Drawdown

Board Appointments

Financial Results

Leadership Changes

Financial Results

Management Changes

Financial Update

Entry into Material Definit...

Earnings Report

Credit Agreement

Dismissal of Independent Re...

Earnings Reports

Financial Update

Grant of Stock Option

Financial Update

Financial Results Announcement

Equity Purchase Agreement

Merger of Equals

Special Meeting Approval

Submission of Matters to a ...

Supplemental Disclosures

Rights Offerings

Equity Issuance

Promissory Note Issued

Merger Agreement with TriSa...

Merger Agreement and Subscr...

Merger Agreement

Merger Agreement

Merger Agreement

Merger Agreement and Amendm...

Merger Agreement with TriSa...

Merger Agreement

External Links:

Trisalus Life Sciences, Inc. announced preliminary unaudited financial results for the year ended December 31, 2023, showing revenue growth of approximately 77% for Q4 2023 and 49% for the full year 2023 compared to the previous year.

AI Assistant

TRISALUS LIFE SCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.